Dermapharm Holding SE (ETR:DMP)
38.30
-0.50 (-1.29%)
Sep 10, 2026, 5:35 PM CET
Dermapharm Holding SE Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Dermapharm Holding SE stock has a consensus rating of "Buy" and an average price target of €51.00. The average 1-year stock price forecast is 33.16% higher than the current stock price, while the lowest is €44.00 (+14.88%) and the highest is €60.00 (+56.66%).
Price Target: €51.00 (+33.16%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dermapharm Holding SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 2 |
| Hold | 2 | 2 | 2 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains €44.00 | Hold | Maintains | €44.00 | +14.88% | Sep 1, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains €60.00 | Buy | Maintains | €60.00 | +56.66% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
1.21B
from 1.17B
Increased by 3.66%
Revenue Next Year
1.25B
from 1.21B
Increased by 3.80%
EPS This Year
2.61
from 2.56
Increased by 2.26%
EPS Next Year
2.97
from 2.61
Increased by 13.56%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.